126
Views
1
CrossRef citations to date
0
Altmetric
LEYDIG CELL HYPOPLASIA

A novel variant in LCHGR gene in 3 siblings with type 1 Leydig cell hypoplasia

, ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 1136-1139 | Received 28 Mar 2020, Accepted 27 Jun 2020, Published online: 10 Jul 2020

References

  • Witchel SF. Disorders of sex development. Best Pract Res Clin Obstet Gynaecol. 2018;48:90–102.
  • Richter-Unruh A, Martens JWM, Verhoef-Post M, et al. Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clin Endocrinol (Oxf). 2002;56(1):103–112.
  • Athanasoulia AP, Stalla GK, Auer MK. Insights into the coexistence of two mutations in the same LHCGR gene locus causing severe Leydig cell hypoplasia. Hormones (Athens). 2014;13(3):424–429.
  • Vezzoli V, Duminuco P, Vottero A, et al. A new variant in signal peptide of the human luteinizing hormone receptor (LHCGR) affects receptor biogenesis causing Leydig cell hypoplasia. Hum Mol Genet. 2015;24(21):6003–6012.
  • Neyzi O, Bundak R, Gökçay G, et al. Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol. 2015;7(4):280–293.
  • Martens JWM, Lumbroso S, Verhoef-Post M, et al. Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: abnormal processing causes signaling deficiency. J Clin Endocrinol Metab. 2002;87(6):2506–2513.
  • Kossack N, Simoni M, Richter-Unruh A, et al. Mutations in a novel, cryptic exon of the luteinizing hormone/chorionic gonadotropin receptor gene cause male pseudohermaphroditism. PLoS Med. 2008;5(4):e88.
  • Rice AM, Rivkees SA. Receptor transduction of hormone action. In: Sperling MA, editor. Pediatric endocrinology. Philadelphia (PA): Saunders Elsevier; 2008. p. 26–73.
  • Ross AJ, Capel B. Signaling at the crossroads of gonad development. Trends Endocrinol Metab. 2005;16(1):19–24.
  • Mendonca BB, Domenice S, Arnhold IJ, et al. 46XY Disorders of sex development (DSD). Clin Endocrinol. 2009;70(2):173–187.
  • Themmen APN, Martens JWM, Brunner HG. Activating and inactivating mutations in LH receptors. Mol Cell Endocrinol. 1998;145(1–2):137–142.
  • Themmen APN, Verhoef-Post M. LH Receptor defects. Semin Reprod Med. 2002;20(3):199–204.
  • Toledo SP. Leydig cell hypoplasia leading to two different phenotypes: male pseudohermaphroditism and primary hypogonadism not associated with this. Clin Endocrinol. 1992;36(5):521–522.
  • Mendonca BB, Costa EMF, Belgorosky A, et al. 46,XY DSD due to impaired androgen production. Best Pract Res Clin Endocrinol Metab. 2010;24(2):243–262.
  • Segaloff DL. Diseases associated with mutations of the human lutropin receptor. Prog Mol Biol Transl Sci. 2009; 89:97–114.
  • Latronico AC, Arnhold IJP. Gonadotropin resistance. Endocr Dev. 2013;24:25–32.
  • Latronico AC, Arnhold IJ. Inactivating mutations of the human luteinizing hormone receptor in both sexes. Semin Reprod Med. 2012;30(5):382–386.
  • Gromoll J, Eiholzer U, Nieschlag E, et al. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab. 2000;85(6):2281–2286.
  • Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev. 2000; 21:551–583.
  • Troppmann B, Kleinau G, Krause G, et al. Structural and functional plasticity of the luteinizing hormone/choriogonadotrophin receptor. Hum Reprod Update. 2013;19(5):583–602.
  • Laue LL, Wu SM, Kudo M, et al. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol. 1996;10(8):987–997.
  • Yan M, Dilihuma J, Luo Y, et al. Novel compound heterozygous variants in the LHCGR gene in a genetically male patient with female external genitalia. J Clin Res Pediatr Endocrinol. 2019;11(2):211–217.
  • Newton CL, Anderson RC, Katz AA, et al. Loss-of-function mutations in the human luteinizing hormone receptor predominantly cause intracellular retention. Endocrinology. 2016;157(11):4364–4377.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.